Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 06-2005 | 09-2004 | 09-2003 | 09-2002 | |
| Sales | 1,994 | 202 | 0 | 0 | 0 |
| Cost of Goods | 3,815 | 1,474 | N/A | N/A | N/A |
| Gross Profit | -1,821 | -1,273 | N/A | N/A | N/A |
| Operating Expenses | 6,190 | 3,185 | 9 | 19 | 8 |
| Operating Income | -7,195 | -3,983 | -9 | -19 | -8 |
| Interest Expense | 689 | 168 | 2 | 41 | 52 |
| Other Income | -334 | -119 | 0 | 0 | 0 |
| Pre-tax Income | -8,218 | -4,269 | -11 | -60 | -59 |
| Net Income Continuous | -8,218 | -4,269 | -11 | -60 | -59 |
| Net Income Extraordinary | N/A | N/A | 87 | N/A | N/A |
| Net Income | $-8,218 | $-4,269 | $76 | $-60 | $-59 |
| EPS Basic Total Ops | -6.80 | -7.80 | -0.30 | -0.70 | -3.00 |
| EPS Basic Continuous Ops | -6.82 | -7.80 | -0.10 | -0.70 | -1.79 |
| EPS Diluted Total Ops | -6.80 | -7.80 | -0.30 | -0.70 | -3.00 |
| EPS Diluted Continuous Ops | -6.82 | -7.80 | -0.10 | -0.70 | -1.79 |
| EBITDA(a) | $-6,536 | $-3,761 | $-9 | $-19 | $-8 |